Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer ; volume:15 ; number:1 ; day:1 ; month:5 ; year:2017 ; pages:1-16 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (1.5.2017), 1-16, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Chen, Ina
- Contributor
-
Mathews-Greiner, Lesley
Li, Dandan
Abisoye-Ogunniyan, Abisola
RAY, SATYAJIT
Bian, Yansong
Shukla, Vivek
Zhang, Xiaohu
Guha, Raj
Thomas, Craig
Gryder, Berkley
Zacharia, Athina
Beane, Joal D.
Ravichandran, Sarangan
Ferrer, Marc
Rudloff, Udo
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1197-5
- URN
-
urn:nbn:de:1111-201705121480
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Ina
- Mathews-Greiner, Lesley
- Li, Dandan
- Abisoye-Ogunniyan, Abisola
- RAY, SATYAJIT
- Bian, Yansong
- Shukla, Vivek
- Zhang, Xiaohu
- Guha, Raj
- Thomas, Craig
- Gryder, Berkley
- Zacharia, Athina
- Beane, Joal D.
- Ravichandran, Sarangan
- Ferrer, Marc
- Rudloff, Udo
- SpringerLink (Online service)
Other Objects (12)
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin–EGFR crosstalk
Building Information Modeling Supporting LEED Sustainability Certification – Streamlining the Required Documentation with BIM Tools
MIR194-2HG, a miRNA host gene activated by HNF4A, inhibits gastric cancer by regulating microRNA biogenesis
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
A novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression
Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K/AKT axis
lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1
LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex
Gastric cancer
Gastric cancer
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
Gastric Cancer: A Practical Review on Management of Individuals with Hereditary or Familial Risk for Gastric Cancer
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin–EGFR crosstalk
Building Information Modeling Supporting LEED Sustainability Certification – Streamlining the Required Documentation with BIM Tools
MIR194-2HG, a miRNA host gene activated by HNF4A, inhibits gastric cancer by regulating microRNA biogenesis
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
A novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression
Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K/AKT axis
lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1
LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex
Gastric cancer
Gastric cancer
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
Gastric Cancer: A Practical Review on Management of Individuals with Hereditary or Familial Risk for Gastric Cancer
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin–EGFR crosstalk
Building Information Modeling Supporting LEED Sustainability Certification – Streamlining the Required Documentation with BIM Tools
MIR194-2HG, a miRNA host gene activated by HNF4A, inhibits gastric cancer by regulating microRNA biogenesis
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
A novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression
Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K/AKT axis
lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1
LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex
Gastric cancer
Gastric cancer
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts